Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC

Nivolumab and salvage nivolumab plus ipilimumab for aRCC

Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations

Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer

IMvigor130 study: Final OS analysis of atezo + plt/gem vs placebo + plt/gem used to treat mUC

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

L'importance de choisir judicieusement les médicaments anticancéreux

Choosing Wisely in haemato oncology and medical oncology

Choosing Wisely in haemato-medical oncology

Choisir judicieusement en oncologie chirurgicale

Choosing Wisely campaigns in Africa

Etat des lieux de la lutte contre le cancer au Sénégal: investissons-nous à bon escient dans les spécialistes locaux?